News > News > Abbott unit’s divisional patent application for drug rejected in India

Abbott unit’s divisional patent application for drug rejected in India

January 5, 2016

The country’s patent office has rejected a divisional patent application by AbbVie Biotechnology Ltd, the biopharmaceutical arm of US-based Abbott Laboratories…

By: Sajan C Kumar | Chennai | December 26, 2015 12:18 AM

http://www.financialexpress.com/article/industry/companies/abbott-units-divisional-patent-application-for-drug-rejected-in-india/